Patient safety promotion in community pharmacy based on the knowledge gained through adverse event reporting system with Professor Shin Ushiro
Date: 6 April 2017
Presenter: Professor Shin Ushiro, Executive Board Member - Japan Council for Quality Health Care, Professor and Director, Division of Patient Safety, Kyushu University Hospital
Track 3: Patient Safety
"This webinar was very beneficial as it was about the importance of the consequences of medication errors which is an important issue where patient safety in health care is concern. I enjoyed mostly the case study on Methotrexate."
Deputy Director of Credentialing and Quality Assurance, Ghana
"This webinar allowed me to learn what others are doing in the medication safety space - we are commencing on a medication reconciliation collaborative in 2018 across our 7 hospitals so it will be good to review the WHO Global Patient Safety program. The data was great!”
Manager Innovation, Australia
About the Webinar
Significantly frequent near-miss events are supposed to happen in community pharmacies. Japan Council for Quality Health Care (JQ) launched a project to collect and study near-miss of community pharmacy in 2008. It is of note that 20% of cases are related to “Inquiry on prescription” while others are related to “Dispensing”. Inquiry is a vital function of a pharmacist in providing with healthcare according to “Pharmacist Law”. It has been elucidated that errors could be corrected through the adequate inquiry. In the webinar, the role of the community pharmacy for patient safety promotion is to be reviewed.
By the end of this webinar, learners will:
- Understand the way adverse event takes place between hospital/clinic and community pharmacy.
- Be aware of the importance of clarification by pharmacist on questionable prescription for medication safety.
- Understand the significance and spectrum of various documents and materials which could be produced by successful reporting/learning system.
- Learn that it is possible to create no-blame culture for enhancing adverse event reporting.
- Be encouraged to involve regulative authority and pharmaceutical industry for medication safety.
A) Healthcare professionals and others involved in drug manufacturing and approval.
B) Physicians, pharmacists, nurses, healthcare assistants working in medical institutions, community pharmacy and nursing care facilities.
C) Policy makers, manufacturers and others working on drug manufacturing and approval.
D) In addition to A)-D), those who are involved in patient safety research, risk management and quality improvement.
About the Presenter
Professor Shin Ushiro is Executive Board Member for Japan Council for Quality Health Care and Professor of the Division of Patient Safety Management- Kyushu University Hospital, Kyushu University Graduate School of Medicine. He currently is an ISQua Expert. He serves as a member on patient safety or clinical research in various scientific entities. His main theme is to promote patient safety based on lessons learned from intramural and/or nationwide adverse event (AE) reporting/learning system. He has been engaged in nationwide AE reporting system for approximately ten years in JQ and compiled dozens of quarterly reports and monthly alerts.